← All stocks

Elicio Therapeutics, Inc.

ELTX No buying or selling
CIK 0001601485 #4465 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Chudnovsky Yekaterina
Director
5,416,212
$31.47M
+182.7%
Venkatesan Jay
Director
179,581
$1.04M
+38.6%
Connelly Robert
CEO, President and Director
120,570
$700.51K
+156.7%
Haqq Christopher
See Remarks
57,381
$333.38K
+79.4%
Shah Preetam
See Remarks
24,000
$139.44K
DeMuth Peter
Chief Scientific Officer
21,543
$125.16K

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 10,791,326 to 26,281,882 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 7
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 8 Feb 2021